Gay, Bisexual Men Report Higher Rates of Skin Cancer Than Heterosexual Men
the ONA take:
Gay and bisexual men indoor tan more frequently and report higher rates of skin cancer than heterosexual men, a new study published online ahead of print in JAMA Dermatology has shown.
Because indoor tanning, which is highly associated with skin cancer, has been suggested to be more common among sexual minority men compared with heterosexual men, researchers sought to evaluate whether skin cancer prevalence and indoor tanning behaviors differ by sexual orientation.
For the cross-sectional study, researchers analyzed data from the 2001, 2003, 2005, and 2009 California Health Interview Surveys and the 2013 National Health Interview Survey.
A total of 192,575 men and women 18 years or older identified as heterosexual or a sexual minority (homosexual, gay, or bisexual). Of those, 78,487 were heterosexual men, 3,083 were sexual minority men, 107,976 were heterosexual women, and 3,029 were sexual minority women.
Results showed that sexual minority men were more likely than heterosexual men to report having skin cancer and having tanned indoors, while sexual minority women were less likely than heterosexual women to report having tanned indoors and having had nonmelanoma skin cancer.
“Our hope is that this finding will help increase awareness among health care providers that gay and bisexual men constitute a high-risk population for skin cancer, which in turn will lead to increased public health education and more diligent skin cancer screening in this group of men,” Sarah Arron, MD, PhD, a UCSF associate professor of dermatology, said.
“Recent research suggests that, fortunately, screening can increase early detection and decrease mortality from this disease.”
Gay and bisexual men indoor tan more frequently and report higher rates of skin cancer than heterosexual men.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- Screening Recommendations for Children with Common Cancer Predisposition Syndromes
- Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Lack of Transfusion Services a Barrier to Hospice Care for Patients With Blood Cancers
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Ethnic Differences, Cultural Barriers Negatively Impact Mammography Follow-up Among Asian Ethnic Groups
- Study Questions Safety of E-cigarettes vs Regular Tobacco Cigarettes
- Changes in Pulmonary Function Tests in Breast Carcinoma Patients Treated With Locoregional Post-mastectomy Radiotherapy: Results of a Pilot Study
- Increases in Liver Cancer Incidence Influenced by Higher Rates of Comorbidities
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|